Amy Li
Impact in
-
- Diphtheria, Corynebacterium, and Tetanus
Papers in
-
- Hedgehog Signaling Pathway Studies 3
- Metabolomics and Mass Spectrometry Studies 2
- Surgery 3
- Cholesterol and Lipid Metabolism 3
- Co-authors
- Libin Xu (13 shared papers)Kelly M. Hines (3 shared papers)Stefano Monti (1 shared paper)Ilya Alexandrov (1 shared paper)Michael Y. Sherman (1 shared paper)Xiongbin Lu (1 shared paper)Yongmei Wang (1 shared paper)Julia A. Yaglom (1 shared paper)
- Journals
- Analytical and Bioanalytical Chemistry (1 paper)Scientific Reports (1 paper)The Journal of Cell Biology (1 paper)Nature Communications (1 paper)The Analyst (1 paper)
- Partner nations
- United StatesIsraelAustralia
In The Last Decade
Amy Li
16 papers receiving 187 citations
Peers
Comparison fields: 5 of 60
- Aging 5
- Endocrinology 14
- Microbiology 15
- Molecular Biology 144
- Clinical Biochemistry 11
Countries citing papers authored by Amy Li
This map shows the geographic impact of Amy Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Amy Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Amy Li more than expected).
Fields of papers citing papers by Amy Li
This network shows the impact of papers produced by Amy Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Amy Li. The network helps show where Amy Li may publish in the future.
Co-authors
The 25 scholars most cited alongside Amy Li, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2018 | 49 | |
| 2 | 2019 | 28 | |
| 3 | 2020 | 22 | |
| 4 | 2020 | 18 | |
| 5 | 2021 | 16 | |
| 6 | 2000 | 16 | |
| 7 | 2022 | 16 | |
| 8 | 2022 | 6 | |
| 9 | 2024 | 3 | |
| 10 | 2023 | 3 | |
| 11 | 2022 | 3 | |
| 12 | 2024 | 2 | |
| 13 | 2019 | 2 | |
| 14 | 2025 | 2 | |
| 15 | 2023 | 2 | |
| 16 | 2020 | 1 |
About Amy Li
Amy Li is a scholar working on Molecular Biology, Surgery, Genetics, Biochemistry and Pulmonary and Respiratory Medicine, having authored 16 papers that have together received 189 indexed citations. Recurring topics across this work include Hedgehog Signaling Pathway Studies (3 papers), Lipid metabolism and biosynthesis (3 papers), Cholesterol and Lipid Metabolism (3 papers), Genetic and Kidney Cyst Diseases (2 papers), Cancer, Lipids, and Metabolism (2 papers), Bacterial Identification and Susceptibility Testing (2 papers), Ferroptosis and cancer prognosis (2 papers) and Metabolomics and Mass Spectrometry Studies (2 papers). The work is most often cited by research in Aging (5 citations), Endocrinology (14 citations), Microbiology (15 citations), Molecular Biology (144 citations) and Clinical Biochemistry (11 citations). Amy Li has collaborated with scholars based in United States, Israel and Australia. Frequent co-authors include Libin Xu, Kelly M. Hines, Stefano Monti, Ilya Alexandrov, Michael Y. Sherman, Xiongbin Lu, Yongmei Wang, Julia A. Yaglom, David R. Raleigh and David W. Baggett. Their work appears in journals such as Analytical and Bioanalytical Chemistry, Scientific Reports, The Journal of Cell Biology, Nature Communications and The Analyst.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.